GHK-Cu: A Copper Tripeptide With a 37-Year Paper Trail

The short version

GHK-Cu is a tiny copper-carrying molecule made of three amino acids — glycine, histidine and lysine — bound to a copper ion. It occurs naturally in the body, inside human collagen, and its level in blood plasma falls with age ^[4]. Applied to skin, it is best studied as a cosmetic ingredient called Copper Tripeptide-1, where it has one of the longer published safety records of any peptide sold as "anti-aging."

The strongest human evidence is topical: in reviewed studies, procollagen synthesis increased in about 70% of people using GHK-Cu, compared with 50% for vitamin C and 40% for retinoic acid ^[1][4]. A separate hair-growth trial of a related copper-peptide formula showed a statistically significant increase in hair count over placebo ^[3]. What is not well established is anything about taking GHK-Cu into the body by injection — that use is unapproved, unstudied in controlled human trials, and treated on this page as experimental, not as a documented benefit.

What it is

GHK-Cu is a linear tripeptide — glycyl-L-histidyl-L-lysine — chelated to a copper(II) ion in a 1:1 ratio through the histidine, glycine and an amide nitrogen, leaving the lysine side chain free to interact with cell-surface receptors. Its molecular formula is C14H23CuN6O4+, and it occurs endogenously within the alpha-2(I) chain of type I collagen and in the protein SPARC/osteonectin. As skin ages, GHK-Cu's plasma concentration drops sharply — from roughly 200 nanograms per milliliter at age 20 to about 80 nanograms per milliliter by age 60 ^[4] — which is the observation that first pointed researchers toward its role in tissue maintenance.

On ingredient labels it usually appears as Copper Tripeptide-1, and it is a legal, widely marketed cosmetic ingredient in the United States, EU and UK. Injectable or oral systemic GHK-Cu is a different regulatory story entirely: it has no approved indication and no validated human pharmacokinetic data by that route.

How it works

GHK-Cu functions as both a copper chaperone and a signaling molecule. At extremely low concentrations — picomolar to nanomolar — it stimulates dermal fibroblasts to synthesize collagen, elastin, glycosaminoglycans and the proteoglycan decorin, while shifting the balance between matrix-remodeling enzymes (matrix metalloproteinases) and their inhibitors ^[6][7]. The bound copper ion supports an enzyme called lysyl oxidase, which cross-links collagen and elastin fibers, and gives GHK-Cu antioxidant activity resembling the enzyme superoxide dismutase.

Gene-expression analysis found that GHK alters expression of roughly 31.2% of human genes at a 50%-or-greater change threshold — about 59% upregulated and 41% downregulated — with strong effects on wound-repair, DNA-repair, antioxidant and protein-quality-control (ubiquitin-proteasome) gene sets, alongside suppression of NF-kB-driven inflammatory signaling ^[2]. A widely repeated claim that GHK modulates "about 4,000 genes" is an extrapolation beyond that verified threshold; the dataset that actually meets the 50%-or-greater bar is closer to 2,100 genes ^[2].

What the research shows

A 2025 review is the most current synthesis: it confirms GHK-Cu's central formulation problem — poor stratum-corneum permeability, with a clogP of -2.24 that makes it hard for the intact peptide to cross skin's outer barrier — and evaluates two workarounds, palmitoylation (which raises clogP to 1.14) and microneedle pretreatment, which allowed roughly 134 nanomoles of GHK to permeate skin that was otherwise impermeable to it ^[1]. The same review reports procollagen synthesis increased in 70% of GHK-Cu-treated subjects, against 50% for vitamin C and 40% for retinoic acid ^[1].

A six-month randomized trial in 45 men with male-pattern hair loss tested a complex of 5-aminolevulinic acid and glycyl-histidyl-lysine peptide against placebo. Hair count rose by 52.6 at the higher concentration and 71.5 at the lower one, versus 9.6 with placebo (p<0.05), with no adverse events reported in any group ^[3] — the strongest controlled human efficacy signal in this dataset, though it tested a combination formulation rather than GHK-Cu alone.

A human skin-penetration study quantified how much copper actually gets into the dermis when delivered as GHK-Cu: over 48 hours, roughly 136.2 micrograms per square centimeter permeated the skin, and about 97 micrograms per square centimeter was retained as a depot in the dermal layer ^[5]. The foundational 1988 cell-culture study that started this whole line of research found GHK-Cu stimulated collagen synthesis in human fibroblasts beginning at concentrations between 10^-12 and 10^-11 molar, peaking at 10^-9 molar, independent of any change in cell number — evidence of a specific metabolic effect rather than simply more cells making more collagen ^[7].

Reported effects, cautions & safety

Community reports of using topical copper-peptide products are anecdotal, not clinical evidence, and are compiled here from skincare forums, product-review pages and community guides rather than from controlled studies.

Commonly reported (anecdotal, not clinical evidence): firmer, tighter-feeling skin is the single most common thing users describe, typically building over several weeks of twice-daily use. Softer fine lines, better hydration within the first week or two, and smoother texture with a brighter appearance are also frequently mentioned. A smaller group applies copper-peptide scalp serums and reports less shedding and thicker-feeling hair over several months, usually alongside other approaches such as microneedling.

Commonly reported adverse experiences (anecdotal, not clinical evidence): irritation — redness, itching or dryness — is the most frequent complaint, especially in people with sensitive skin or those starting at a high concentration. Some acne-prone users describe a short "purging" phase of minor breakouts. A widely repeated piece of community troubleshooting is that copper peptides seem to lose potency or cause irritation when layered with vitamin C or strong exfoliating acids in the same routine — advice that lines up with the formulation chemistry described below.

Cited cautions from the literature:

• Injectable or systemic use is unapproved and effectively unstudied in humans. Topical Copper Tripeptide-1 has a long cosmetic safety record, but the only pharmacokinetic data behind injectable use comes from rodent work showing the free peptide is broken down quickly in the bloodstream — not from human trials.
• Do not combine with vitamin C or strong acids in the same skincare step. Ascorbic acid and low-pH exfoliants can break apart the copper-peptide complex, wasting both actives and potentially increasing irritation; the peptide is most stable at a mildly acidic-to-neutral pH ^[1].
• Human evidence remains limited and mostly small-scale. The strongest data come from small topical trials, and broader anti-aging claims lean heavily on cell, rodent and gene-database studies, many from a single research group — a reason to keep expectations calibrated to what was actually measured ^[1][4].
• Copper coordination is required for the documented effects. Plain GHK without bound copper does not reproduce key laboratory findings, which is why the form used in a given study — GHK versus GHK-Cu — matters when reading any claim about this compound.

Where it fits in lab-grade standards

GHK-Cu is a useful test case for what "lab-grade" purity actually buys a reader. Because it is legally sold as a cosmetic ingredient, Copper Tripeptide-1 formulations are subject to cosmetic-safety norms rather than pharmaceutical manufacturing controls — a meaningfully different bar than the one tesamorelin clears as an approved drug. A chromatography certificate for injectable research-grade GHK-Cu can confirm what a specific vial contained on the day it was tested; it cannot confirm that the copper complex stayed intact through storage, or substitute for the human trial data that route of use does not have. Reading the delivery-science literature — clogP values, permeation studies, dermal-depot measurements ^[1][5] — is a more reliable way to judge a formulation claim than a purity number alone. See how the three compare on evidence maturity.